| Sjan Corp | |
|
113 Ocean Sands Ct Myrtle Beach SC 29579-3590 | |
| (843) 231-9966 | |
| (866) 226-7650 |
| Full Name | Sjan Corp |
|---|---|
| Speciality | Internal Medicine |
| Location | 113 Ocean Sands Ct, Myrtle Beach, South Carolina |
| Authorized Official Name and Position | Solomon Jan (MD/OWNER) |
| Authorized Official Contact | 8002947001 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sjan Corp 113 Ocean Sands Ct Myrtle Beach SC 29579-3590 Ph: (843) 231-9966 | Sjan Corp 113 Ocean Sands Ct Myrtle Beach SC 29579-3590 Ph: (843) 231-9966 |
| NPI Number | 1104564947 |
|---|---|
| Provider Enumeration Date | 05/23/2022 |
| Last Update Date | 05/23/2022 |
| Medicare PECOS PAC ID | 6800270711 |
|---|---|
| Medicare Enrollment ID | O20220826000092 |
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
Catalent Pharma Solutions announces the recent successful completion of the first FDA general cGMP audit and pre-approval inspection of its Buenos Aires, Argentina pharmaceutical softgel facility, with no reported observations on FDA Form 483.
The University of Texas MD Anderson Cancer Center and AstraZeneca today announced a multiyear strategic research collaboration to conduct multiple, parallel clinical and clinically related studies in ovarian and other gynecologic cancers with the aim of improving patient outcomes.
Physicians with California Pacific Medical Center are among the first in the nation to use a new advanced mapping technology to help treat patients suffering from debilitating and potentially dangerous heart rhythm disorders.
Americans are increasingly eating more of their meals prepared away from home, and this is particularly true among African Americans, who also have higher rates of obesity than other Americans. Young adults tend to eat out more often at fast-food restaurants and these establishments are more often found in minority neighborhoods.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104564947 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Solomon A Jan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1457538316 PECOS PAC ID: 0547344087 Enrollment ID: I20150428001984 |
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
Catalent Pharma Solutions announces the recent successful completion of the first FDA general cGMP audit and pre-approval inspection of its Buenos Aires, Argentina pharmaceutical softgel facility, with no reported observations on FDA Form 483.
The University of Texas MD Anderson Cancer Center and AstraZeneca today announced a multiyear strategic research collaboration to conduct multiple, parallel clinical and clinically related studies in ovarian and other gynecologic cancers with the aim of improving patient outcomes.
Physicians with California Pacific Medical Center are among the first in the nation to use a new advanced mapping technology to help treat patients suffering from debilitating and potentially dangerous heart rhythm disorders.
Americans are increasingly eating more of their meals prepared away from home, and this is particularly true among African Americans, who also have higher rates of obesity than other Americans. Young adults tend to eat out more often at fast-food restaurants and these establishments are more often found in minority neighborhoods.
› Verified 6 days ago
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
Catalent Pharma Solutions announces the recent successful completion of the first FDA general cGMP audit and pre-approval inspection of its Buenos Aires, Argentina pharmaceutical softgel facility, with no reported observations on FDA Form 483.
The University of Texas MD Anderson Cancer Center and AstraZeneca today announced a multiyear strategic research collaboration to conduct multiple, parallel clinical and clinically related studies in ovarian and other gynecologic cancers with the aim of improving patient outcomes.
Physicians with California Pacific Medical Center are among the first in the nation to use a new advanced mapping technology to help treat patients suffering from debilitating and potentially dangerous heart rhythm disorders.
Americans are increasingly eating more of their meals prepared away from home, and this is particularly true among African Americans, who also have higher rates of obesity than other Americans. Young adults tend to eat out more often at fast-food restaurants and these establishments are more often found in minority neighborhoods.
› Verified 6 days ago
Southeastern Hospitalist Services Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 809 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-692-1000 | |
Traditions Health Of Augusta Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 215 Ronnie Ct Ste D, Myrtle Beach, SC 29579 Phone: 843-504-3421 Fax: 843-504-3422 | |
Strand Regional Specialty Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8170 Rourk St, Myrtle Beach, SC 29572 Phone: 843-449-2336 Fax: 843-497-2505 | |
Healogics Specialty Physicians Of South Carolina, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5050 Highway 17 Byp S, Myrtle Beach, SC 29588 Phone: 843-839-6000 | |
Carolina Health Specialists Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4591 Socastee Blvd, Myrtle Beach, SC 29588 Phone: 843-497-5929 Fax: 843-293-1115 | |
La Bella Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2020 Oakheart Rd, Myrtle Beach, SC 29579 Phone: 843-424-3015 | |
Jga Medical Ventures, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4798 Woodview Ln, Myrtle Beach, SC 29575 Phone: 843-828-3352 Fax: 843-357-1471 |